
| Monday 6 September, 2010 |



Vitrolife
Vitrolife develops, manufactures and sells advanced products and systems for preparation, cultivation and storage of human cells, tissue and organs. The company operates within three main product areas: Fertility, Transplantation and Stem Cell Cultivation.
www.vitrolife.com
"It is truly pleasing and stimulating for all of us at Vitrolife to have our efforts to achieve global market coverage within our niche recognized in this way", says Magnus Nilsson, CEO, Vitrolife.
Carmel Pharma
Carmel Pharma manufactures Pha Seal, a closed-system for handling of dangerous drugs for intravenous use. The biggest application area is for chemotherapy in cancer treatment, and customers consist mainly of hospital pharmacies and oncology nurses at cancer clinics.
www.carmelpharma.se
“It is immensely gratifying for us at Carmel Pharma that we have been nominated for this award. Since we have made huge investments and adopted a long-term strategic approach over a number of years with a firm eye on achieving substantial export growth, it is all the more rewarding to note that we are being recognised by the Swedish Trade Council for our work," says Dan Pitulia, CEO of Carmel Pharma.
The jury consists of Ulf Berg, President of the Swedish Trade Council, Börje Ekholm, President and CEO of Investor AB, Björn Fjellsäter, CEO of BoB Management, Mauro Gozzo, Chief Economist of the Swedish Trade Council, Sven-Christer Nilsson, Chairman of the Board of Ripasso and Ray Mauritsson, President of Axis Communications.
More information about the Grand Export Award that will be presented on April 19 is available from www.swedishtrade.se/storaexportpriset
.
For further information please contact:
Mauro Gozzo, Chief Economist, Swedish Trade Council,
phone +46 8-588 660 35
Caroline Karlsson, Press Officer, Swedish Trade Council
phone +46 8-588 662 07, 076- 114 77 94